Prihlásiť sa Zaregistrujte sa zadarmo

1 ročný cieľ spoločnosti Æterna Zentaris

Aká je hodnota metriky 1 ročný cieľ spoločnosti Æterna Zentaris?

Hodnota metriky 1 ročný cieľ spoločnosti Æterna Zentaris, Inc. je CAD$5 -36.72%

Aká je definícia metriky 1 ročný cieľ?

1-ročný cieľ (1-year target) je analytikmi predpokladaná cena akcie za rok od dnešného dňa.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

1 ročný cieľ spoločností v sektore Health Care sektor na TSX v porovnaní so spoločnosťou Æterna Zentaris

Čomu sa venuje spoločnosť Æterna Zentaris?

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

Firmy s metrikou 1 ročný cieľ podobnou spoločnosti Æterna Zentaris



  • Hodnota metriky 1 ročný cieľ spoločnosti SJM je HKD$4 +70.39%
  • Hodnota metriky 1 ročný cieľ spoločnosti Aurizon je AUD$4 +16.03%
  • Hodnota metriky 1 ročný cieľ spoločnosti Domain Australia je AUD$4 +40.14%
  • Hodnota metriky 1 ročný cieľ spoločnosti Technovator International je HKD$5 +1,676.05%
  • Hodnota metriky 1 ročný cieľ spoločnosti Canada Nickel je CAD$4 +282.69%
  • Hodnota metriky 1 ročný cieľ spoločnosti Beter Bed N.V je €4 -33.44%
  • Hodnota metriky 1 ročný cieľ spoločnosti Æterna Zentaris je CAD$5 -36.72%
  • Hodnota metriky 1 ročný cieľ spoločnosti Fullshare je HKD$5 +1,124.35%
  • Hodnota metriky 1 ročný cieľ spoločnosti Volex plc je GBX327 -2.65%
  • Hodnota metriky 1 ročný cieľ spoločnosti Stockland Stapled Securities je AUD$4 -23.47%
  • Hodnota metriky 1 ročný cieľ spoločnosti Beijing Capital Land je HKD$5 +67.36%
  • Hodnota metriky 1 ročný cieľ spoločnosti Gogold Resources je CAD$5 +366.53%
  • Hodnota metriky 1 ročný cieľ spoločnosti Kneat.Com Inc je CAD$4 -15.55%